For long winded replies that's got to be up there!
FDA are indeed reviewing stem cell guidelines.
As for not taking notice of the fast tracking policy in Japan, I think it's quite likely that the FDA would take note. I've said it and I don't think you have any right to say it won't happen.
Finally some agreement?
that MSB is making progress, and are at the vanguard of a new wave of medicine. They are securing grants, tax relief etc
But you say it's irrelevant until conclusion of a stage 3 study which demonstrates, unequivocally that MSBs cells work in the target population.
Not entirely irrelevant is it? No!
As you noted with SRX, you can get other uses even if the front line testing is not as highly efficacious as expected.
It still meant revenue for SRX...It's not all or nothing...but you like to pretend that it is for MSB.
Not when there is efficacy already demonstrated at earlier stages...as is the case with MSB.
I can't be bothered with the rest of your post.
The fact is, that MSB is shaping up as an emerging bluechip and it is gaining momentum. Serious investors need to look at the company website and presos and not bother so much with the hair splitting in here IMO.
- Forums
- ASX - By Stock
- MSB
- Ann: Fast Track Access To Potential Japan Investment Incentives
Ann: Fast Track Access To Potential Japan Investment Incentives, page-39
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
98.0¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.118B |
Open | High | Low | Value | Volume |
99.5¢ | $1.02 | 97.0¢ | $2.821M | 2.832M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20688 | 97.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.0¢ | 35000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 76 | 0.995 |
1 | 87 | 0.990 |
1 | 1015 | 0.985 |
1 | 1350 | 0.980 |
1 | 13 | 0.975 |
Price($) | Vol. | No. |
---|---|---|
0.935 | 16793 | 2 |
0.945 | 837 | 2 |
0.950 | 616 | 1 |
0.970 | 9 | 1 |
1.000 | 27101 | 3 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online